Converge Biotech, a healthcare organization based in Hyderabad, has announced that it has entered into a long-term strategic alliance with OncoDNA, a Belgium-based theranostic and genomic company specializing in precision oncology, to personalize care for late stage cancer patients across India.
OncoDNA’s solutions are designed to guide oncologists in the selection of the treatments based on the specific tumor profile of a patient.
With the aim of improving the clinical outcomes of patients living with advanced solid tumors such as breast or lung cancers, Converge Biotech will provide physicians and healthcare providers across India with OncoDNA’s portfolio of diagnostic solutions.
Corina Cucuruzac, Head of Global Distribution of OncoDNA stated, “Giving oncologists access to cancer biomarker testing is key to improve the treatment journey of patients living with cancer. To date, OncoDNA’s solutions have helped more than 20,000 patients worldwide. We are delighted to have found in Converge Biotech a trusted partner to support together the adoption of precision medicine for the benefit of cancer patients in India.”
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.